Role of cathepsin D in prostatic cancer cell growth and its regulation by brefeldin a

World Journal of Urology

Volumn 19, Issue 4, 2001, Pages 234-239

  Konno, Sensuke ^a   Cherry, James P ^a   Mordente, John A ^a   Chapman, John R ^a   Choudhury, Muhammad S ^a   Mallouh, Camille ^a   Tazaki, Hiroshi ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Brefeldin A; Cathepsin D; Prostate cancer

Indexed keywords

ANTIFUNGAL AGENT; BREFELDIN A; CATHEPSIN D;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MALE; METABOLISM; PATHOPHYSIOLOGY; PROSTATE TUMOR;

ANTIBIOTICS, ANTIFUNGAL; BREFELDIN A; CATHEPSIN D; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035431535     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007099     Document Type: Article

References (20)

1. Barrett AJ (1977) Cathepsin D and other carboxyl proteinases. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. North-Holland Biomédical Press, Amsterdam, pp 209-248
2. Chapman JR, Tazaki H, Mallouh C, Konno S (1999) Brefeldin A-induced apoptosis in prostatic cancer DU-145 cells: Possible p53-independent death pathway. BJU Int 83: 703-708
3. Cherry JP, Mordente JA, Chapman JR, Choudhury MS, Tazaki H, Mallouh C, Konno S (1998) Analysis of cathepsin D forms and their clinical implications in human prostate cancer. J Urol 160: 2223-2228
4. Erickson AH (1989) Biosynthesis of lysosomal endopeptidases. J Cell Biochem 40: 31-41
5. Gartenhaus R, Wang P, Hoffmann P (1996) Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with Adriamycin by using a p53-independent pathway. Proc Natl Acad Sei USA 93: 265-268
6. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Ming-Chu T, Mirand EA, Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818
7. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol (Berl) 17: 16-23
8. Konno S, Mordente JA, Chen Y, Wu JM, Tazaki H, Mallouh C (1998) Effects of brefeldin A on androgen receptor-mediated cellular responses in human prostatic carcinoma LNCaP cells. Mol Urol 2: 7-11
9. Mordente JA, Konno S, Chen Y, Wu JM, Tazaki H, Mallouh, C (1998) The effects of brefeldin A (BFA) on cell cycle progression involving the modulation of the retinoblastoma protein (pRB) in PC-3 prostate cancer cells. J Urol 159: 275-279
10. Partin AW, Rattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD (1997) Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: a multiinstitutional update. JAMA 277: 1445-1451
11. Poole AR (1979) Tumor lysosomal enzymes and invasive growth. In: Dingle JT, Fell HB (eds) Lysosomes in biology and pathology. Elsevier, New York pp 304-337
12. Rochefort H, Cavailles V, Augereau P, Capony F, Maudelonde T, Touitou I, Garcia M (1989) Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem Mol Biol 34: 177-182
13. Rochefort H, Capony F, Garcia M (1990) Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications. Cancer Cells 2: 383-388
14. Shao RG, Shimizu T, Pommier Y (1996) Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53. Exp Cell Res 227:190-196
15. Sherr CJ (1993) Mammalian G, cyclins. Cell 73: 1059-1065
16. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281
17. Tamura G, Ando K, Suzuki S, Takatsuki A, Arima K (1968) Antiviral activity of brefeldin A and verrucarin A. J Antibiot (Tokyo) 21: 160-161
18. Thorpe SM, Rochefort H, Garcia M (1985) Association between high concentrations of 52 K cathepsin D and poor prognosis in primary breast cancer. Cancer Res 49: 6008-6014
19. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465
20. Wike-Hooley JL, Haveman J, Reinhold HS (1984) The relevance of tumor pH to the treatment of malignant disease. Radiother Oncol 2: 343-366